Compare IBN & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBN | MDT |
|---|---|---|
| Founded | 1955 | 1949 |
| Country | India | Ireland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.0B | 125.3B |
| IPO Year | 1999 | N/A |
| Metric | IBN | MDT |
|---|---|---|
| Price | $30.90 | $100.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $108.44 |
| AVG Volume (30 Days) | 4.9M | ★ 5.8M |
| Earning Date | 01-26-2026 | 02-17-2026 |
| Dividend Yield | 0.70% | ★ 2.92% |
| EPS Growth | 11.76 | ★ 12.98 |
| EPS | 0.83 | ★ 3.69 |
| Revenue | $21,493,768,246.00 | ★ $34,758,000,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | $13.50 | $5.86 |
| P/E Ratio | ★ $18.12 | $26.38 |
| Revenue Growth | ★ 16.53 | 5.34 |
| 52 Week Low | $27.42 | $79.55 |
| 52 Week High | $34.57 | $106.33 |
| Indicator | IBN | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 63.41 | 59.61 |
| Support Level | $29.64 | $95.17 |
| Resistance Level | $30.20 | $96.99 |
| Average True Range (ATR) | 0.26 | 1.24 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 81.21 | 94.41 |
ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.